1. Home
  2. BIO vs KT Comparison

BIO vs KT Comparison

Compare BIO & KT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$300.28

Market Cap

8.2B

Sector

Industrials

ML Signal

HOLD

Logo KT Corporation

KT

KT Corporation

HOLD

Current Price

$18.68

Market Cap

8.6B

ML Signal

HOLD

Company Overview

Basic Information
Metric
BIO
KT
Founded
1952
1981
Country
United States
South Korea
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Telecommunications Equipment
Sector
Industrials
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
8.2B
8.6B
IPO Year
N/A
1999

Fundamental Metrics

Financial Performance
Metric
BIO
KT
Price
$300.28
$18.68
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$358.50
N/A
AVG Volume (30 Days)
170.4K
1.9M
Earning Date
10-29-2025
02-10-2026
Dividend Yield
N/A
3.54%
EPS Growth
N/A
N/A
EPS
N/A
2.80
Revenue
$2,557,500,000.00
$19,913,724,353.00
Revenue This Year
$1.77
$7.66
Revenue Next Year
$2.30
N/A
P/E Ratio
N/A
$12.81
Revenue Growth
N/A
5.39
52 Week Low
$211.43
$15.49
52 Week High
$373.69
$21.61

Technical Indicators

Market Signals
Indicator
BIO
KT
Relative Strength Index (RSI) 39.06 51.70
Support Level $298.02 $18.65
Resistance Level $307.78 $19.10
Average True Range (ATR) 8.35 0.31
MACD -2.13 0.05
Stochastic Oscillator 16.30 39.15

Price Performance

Historical Comparison
BIO
KT

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About KT KT Corporation

KT is South Korea's largest fixed-line telecom operator, with around 11.5 million fixed-line broadband customers and 9.5 million IPTV customers, and is the second-largest wireless operator with 28 million subscribers. Additionally, it has a number of nontelecom businesses, including real estate, payment processing, artificial intelligence, and IDC/cloud services, many of which are the focus of its growth strategy. The company was formed from the previously government-owned, monopoly telecom business and was listed in 1998. After selling its mobile business in 1994 (forming its mobile competitor, SK Telecom) KT created its own mobile operator in 1997.

Share on Social Networks: